Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
123852-08-4
23978-09-8
23978-55-4
33941-15-0
41775-76-2
66943-05-3
1820605-11-5 | 2-[(2-Amino-3-bromophenyl)disulfanyl]-6-bromoaniline | AA00I0DU | MFCD28166383
1820650-09-6 | 2-Chloro-3-[5-(chloromethyl)-1,2,4-oxadiazol-3-yl]pyridine | AA00I0M4 | MFCD27936854
1820687-74-8 | 3-[(2-Nitrophenyl)amino]-3-phenylpropanoic acid | AA00I0SV | MFCD27935489
1820740-51-9 | 2-Chloro-3-methyl-5-(1,2,3,6-tetrahydropyridin-4-yl)pyridine | AA00I11G | MFCD28143960
1824239-57-7 | tert-Butyl (3-iodocyclobutyl)carbamate | AA00I1AO | MFCD00955758
184637-48-7 | 1-Boc-3-aminopiperidine | AA00I1FM | MFCD01861219
18755-46-9 | 1H-Tetrazole, 5-(2-chloroethyl)- | AA00I1SN | MFCD00123349
1909316-58-0 | Methyl thieno[2,3-d][1,3]thiazole-5-carboxylate | AA00I2QY | MFCD29127449
194471-86-8 | (R,S)-Fmoc-3-amino-4,4,4-trifluoro-butyric acid | AA00I2ZG | MFCD02682449
195314-73-9 | N-Benzyl-n-[(1-benzylpiperidin-4-yl)methyl]amine dihydrochloride | AA00I3AT | MFCD08594065
